| Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] |
| | | | | | | | | | | | | | | | | | Outstanding stock options as of February 28 or 29: | | | 12,936 | | | | 12,936 | | | | | | - | | | | - | | | | | | - | | | | - | | | | | | (12,936 | ) | | | - | | Outstanding stock options as of November 30: | | | - | | | | 12,936 | | | | | | | | | | | | Weighted average exercise price | | | n/a | | | $ | 14.70 | | Weighted average remaining contractual term (in years) | | | n/a | | | | 0.29 | |
|
| Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block] |
| | | | | | | | | | | | | | | | | | Outstanding non-vested restricted stock units as of February 28 or 29: | | | 181,742 | | | | 237,641 | | | | | | - | | | | - | | | | | | (48,084 | ) | | | (55,899 | ) | | | | | (10,000 | ) | | | - | | Outstanding non-vested restricted stock units as of November 30: | | | 123,658 | | | | 181,742 | | | | | | | | | | | | Weighted average grant date fair value | | $ | 12.22 | | | $ | 12.22 | | Weighted average remaining vesting period (in years) | | | 2.47 | | | | 3.47 | |
|